Aurobindo Pharma Limited (AUROPHARMA) — Financial Flexibility Index
Aurobindo Pharma Limited (AUROPHARMA) has a Financial Flexibility Index of 0.25x as of September 2025. Free cash flow of Rs44.62 Billion (operating CF Rs28.85 Billion minus capex Rs15.77 Billion) represents 0% of total liabilities (Rs175.12 Billion). Also explore AUROPHARMA net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aurobindo Pharma Limited Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Aurobindo Pharma Limited across 22 annual periods. Check Aurobindo Pharma Limited (AUROPHARMA) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Aurobindo Pharma Limited (2004–2025)
Year-by-year free cash flow to debt coverage for Aurobindo Pharma Limited. For the full company profile including market capitalisation, see AUROPHARMA stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | Rs58.92 Billion | Rs39.25 Billion | Rs171.38 Billion | ▼ -12.7% |
| 2024 | 0.39x | Rs59.96 Billion | Rs24.35 Billion | Rs152.21 Billion | ▲ +0.6% |
| 2023 | 0.39x | Rs51.07 Billion | Rs23.87 Billion | Rs130.38 Billion | ▼ -52.6% |
| 2022 | 0.83x | Rs77.21 Billion | Rs50.16 Billion | Rs93.48 Billion | ▲ +89.3% |
| 2021 | 0.44x | Rs52.03 Billion | Rs33.29 Billion | Rs119.25 Billion | ▼ -9.2% |
| 2020 | 0.48x | Rs58.12 Billion | Rs43.81 Billion | Rs121.03 Billion | ▲ +87.9% |
| 2019 | 0.26x | Rs32.10 Billion | Rs16.51 Billion | Rs125.62 Billion | ▼ -30.9% |
| 2018 | 0.37x | Rs34.84 Billion | Rs19.55 Billion | Rs94.19 Billion | ▼ -48.9% |
| 2017 | 0.72x | Rs49.73 Billion | Rs32.79 Billion | Rs68.75 Billion | ▲ +120.5% |
| 2016 | 0.33x | Rs29.85 Billion | Rs14.20 Billion | Rs91.02 Billion | ▲ +26.5% |
| 2015 | 0.26x | Rs20.05 Billion | Rs12.37 Billion | Rs77.33 Billion | ▲ +42.9% |
| 2014 | 0.18x | Rs10.37 Billion | Rs6.46 Billion | Rs57.14 Billion | ▲ +54.1% |
| 2013 | 0.12x | Rs5.48 Billion | Rs2.75 Billion | Rs46.56 Billion | ▼ -49.0% |
| 2012 | 0.23x | Rs8.98 Billion | Rs3.26 Billion | Rs38.88 Billion | ▼ -24.8% |
| 2011 | 0.31x | Rs10.51 Billion | Rs3.35 Billion | Rs34.23 Billion | ▲ +7.0% |
| 2010 | 0.29x | Rs8.49 Billion | Rs4.29 Billion | Rs29.58 Billion | ▲ +38.2% |
| 2009 | 0.21x | Rs6.19 Billion | Rs1.36 Billion | Rs29.82 Billion | ▲ +28.5% |
| 2008 | 0.16x | Rs4.05 Billion | Rs1.59 Billion | Rs25.07 Billion | ▲ +20.6% |
| 2007 | 0.13x | Rs3.51 Billion | Rs186.50 Million | Rs26.17 Billion | ▲ +17.5% |
| 2006 | 0.11x | Rs2.13 Billion | Rs-90.50 Million | Rs18.72 Billion | ▼ -64.2% |
| 2005 | 0.32x | Rs4.51 Billion | Rs1.22 Billion | Rs14.15 Billion | ▲ +64.9% |
| 2004 | 0.19x | Rs2.20 Billion | Rs198.90 Million | Rs11.41 Billion | — |